Cancer Epidemiology

Inequalities in cancer occurrence and survival. The influence of policy initiatives on patterns of care, treatment, and patient experience.Determinates of patient experience and place of death. The epidemiology of less common cancers. Using clinical data sets and routine data set links to understand clinical care. The potential use of patient survey data for quality improvement. Novel methods of presenting routine data (maps, funnel charts and control charts) in quality improvement.

020 7378 7688

020 7378 9510

Cancer epidemiology and analysis of cancer care and outcomes at the population level.

020 7188 9286

020 7378 9510

Professor Holmberg's research group is currently working on clinical aspects of breast cancer (e.g. long term outcome after new ipsi- or contralateral breast events), on aetiology of prostate cancer with special emphasis on the role of the metabolic syndrome and on translational research in lung cancer (e.g. the characteristics of long term survivors of lung cancer). The group works closely with Thames Cancer Registry on national and international comparisons of cancer survival. Virtually all the studies are undertaken in a network with Scandinavian and American researchers. The research group also has a strong interest in cancer screening, and in developing new concepts of survival analyses that better accommodate the role of competing risks in an ageing population burdened with cancer. There are plans to further develop programs to aid clinical decision-making related to tumour markers.

020 7188 9286

020 7188 9986

+44 (0)20 7188 7904